Callan Family Office’s T. Rowe Price TROW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$518K Sell
4,560
-106
-2% -$10.8K 0.01% 803
2026
Q1
$421K Sell
4,666
-461
-9% -$44.7K 0.01% 824
2025
Q4
$525K Sell
5,127
-280
-5% -$28.9K 0.01% 772
2025
Q3
$555K Buy
5,407
+331
+7% +$34.8K 0.02% 500
2025
Q2
$490K Buy
5,076
+2,528
+99% +$232K 0.02% 592
2025
Q1
$234K Buy
2,548
+323
+15% +$34.1K 0.02% 493
2024
Q4
$252K Buy
+2,225
New +$258K 0.02% 537

Other funds holding TROW

Callan Family Office's TROW Position: Q2 2026 in Review

Callan Family Office reduced its T. Rowe Price (TROW) stake by 2.3% in Q2 2026, selling an estimated $10.8K and leaving 4,560 shares worth $518K. The position accounts for 0.01% of the portfolio, ranked #803.

Callan Family Office first reported a position in TROW in Q4 2024 and has held it in 7 quarters since. The position peaked at $555K in Q3 2025. 1,169 funds tracked by Wall St. Rank hold TROW as of Q2 2026.

  • Callan Family Office held 4,560 shares of T. Rowe Price worth $518K as of Q2 2026.
  • Callan Family Office sold 106 T. Rowe Price shares in Q2 2026, an estimated $10.8K.
  • T. Rowe Price made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #803 holding.
  • Callan Family Office first reported a position in T. Rowe Price in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's T. Rowe Price position peaked at $555K in Q3 2025.
  • 1,169 funds tracked by Wall St. Rank held T. Rowe Price as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.